Genetic Analysis AS (GA) offers a DNA based comprehensive gut bacteria analysis and has the goal of being a leader within the field of molecular diagnostics of diseases related to gut imbalances.
There is a growing awareness of the effect of the microbes in the gut on health and metabolism of food and drugs. In spite of this, no workable diagnostic tool has been available to gain insights into the complex bacterial community found in the gut.
The GA-map™ technology offers for the first time a rapid, comprehensive and high-throughput gut microbiota analysis. The gut microbiota consists of the bacteria and other microorganisms that are part of the large and small intestine.
GA will focus on five key application areas for use of the GA-map™ technology:
The GA-map™ platform technology is based on a combination of patented technology, a special software package, and in-house know-how. A more detailed information on the GA-map™ technology platform can be found in our Technology Description which is part of the White Paper section. Taken together, the GA-map™ technology platform offers a new and exciting tool to harness the information available from the composition of the gut microbiota.
Please contact us for more information on possible collaborative projects.
Morten L Isaksen PhD, CEO
Fredrik A Dahlsvei 20
Tel: +47 48 32 11 11
Fax: +47 48 32 11 12